OBJECTIVE: The objective of the study was to measure the volumetric bone mineral density (vBMD) using diagnostic computed tomography scans in gynecologic oncology patients. STUDY DESIGN: In a retrospective study, spine and femoral neck (FN) vBMD was measured for 1 year in 40 patients receiving chemotherapy or radiation. RESULTS: There is significant bone loss after chemotherapy, radiation, and a combination of radiation and chemotherapy (P = .0211). In 1 year, the percent reduction in vBMD (±SE) at L1-L2 spine and the FN was a 15.9% (±5.67) and 10.4% (±4.06) in chemotherapy; 11% (±5.68) and 15.8% (±2.56) in radiation; and 21.0% (±7.03) and 3.6% (±3.3.7) in the combined therapy group. Bone loss was evident immediately after treatment and persisted or worsened in most women. CONCLUSION: Gynecologic cancer patients treated with chemotherapy or radiation experience immediate and prolonged bone loss; thus, pre- and posttreatment monitoring of bone loss is important in these patients.
OBJECTIVE: The objective of the study was to measure the volumetric bone mineral density (vBMD) using diagnostic computed tomography scans in gynecologic oncology patients. STUDY DESIGN: In a retrospective study, spine and femoral neck (FN) vBMD was measured for 1 year in 40 patients receiving chemotherapy or radiation. RESULTS: There is significant bone loss after chemotherapy, radiation, and a combination of radiation and chemotherapy (P = .0211). In 1 year, the percent reduction in vBMD (±SE) at L1-L2 spine and the FN was a 15.9% (±5.67) and 10.4% (±4.06) in chemotherapy; 11% (±5.68) and 15.8% (±2.56) in radiation; and 21.0% (±7.03) and 3.6% (±3.3.7) in the combined therapy group. Bone loss was evident immediately after treatment and persisted or worsened in most women. CONCLUSION: Gynecologic cancerpatients treated with chemotherapy or radiation experience immediate and prolonged bone loss; thus, pre- and posttreatment monitoring of bone loss is important in these patients.
Authors: S R Cummings; D M Black; M C Nevitt; W Browner; J Cauley; K Ensrud; H K Genant; L Palermo; J Scott; T M Vogt Journal: Lancet Date: 1993-01-09 Impact factor: 79.321
Authors: Masashi Yagi; Luke Arentsen; Ryan M Shanley; Clifford J Rosen; Louis S Kidder; Leslie C Sharkey; Douglas Yee; Masahiko Koizumi; Kazuhiko Ogawa; Susanta K Hui Journal: Calcif Tissue Int Date: 2014-02-23 Impact factor: 4.333
Authors: D L Kendler; J J Body; M L Brandi; R Broady; J Cannata-Andia; M J Cannata-Ortiz; A El Maghraoui; G Guglielmi; P Hadji; D D Pierroz; T J de Villiers; R Rizzoli; P R Ebeling Journal: Osteoporos Int Date: 2018-09-03 Impact factor: 4.507
Authors: Susanta K Hui; Gregory R Fairchild; Louis S Kidder; Manju Sharma; Maryka Bhattacharya; Scott Jackson; Chap Le; Anna Petryk; Mohammad Saiful Islam; Douglas Yee Journal: Calcif Tissue Int Date: 2013-01-12 Impact factor: 4.333
Authors: Laura E Wright; Jeroen T Buijs; Hun-Soo Kim; Laura E Coats; Anne M Scheidler; Sutha K John; Yun She; Sreemala Murthy; Ning Ma; Helen J Chin-Sinex; Teresita M Bellido; Ted A Bateman; Marc S Mendonca; Khalid S Mohammad; Theresa A Guise Journal: J Bone Miner Res Date: 2015-06-08 Impact factor: 6.741
Authors: Valerio Nardone; Paolo Tini; Stefania Croci; Salvatore Francesco Carbone; Lucio Sebaste; Tommaso Carfagno; Giuseppe Battaglia; Pierpaolo Pastina; Giovanni Rubino; Maria Antonietta Mazzei; Luigi Pirtoli Journal: Quant Imaging Med Surg Date: 2018-02
Authors: Susanta K Hui; Leslie Sharkey; Louis S Kidder; Yan Zhang; Greg Fairchild; Kayti Coghill; Cory J Xian; Douglas Yee Journal: PLoS One Date: 2012-08-06 Impact factor: 3.240